港股行業板塊全線下跌,恆指跌幅擴大至2.3%
uSMART盈立智投10月4日,港股早盤全線下挫,三大指數盡墨,恆生指數跌幅一路震盪走低,下跌2.3%,國企指數下跌2.5%,恆生科技指數下跌2.2%。
盤面上,幾乎所有行業板塊下跌,醫藥股跌幅居前。中國恆大、恆大物業今起停牌。
僅有航空板塊走高,中國國航漲7.3%,中國南方航空漲4.5%,國泰航空漲4.5%。
飼料板塊走高,主要因卜蜂國際獲私有化要約大漲逾14%。要約人CPF Investment Limited要求董事會向計劃股東提出該建議,註銷價每股計劃股份1.15港元,較9月24日收市價每股股份0.96港元溢價約19.79%。
此外表現較好的個股還有聯想集團、新東方-S等。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.